100 likes | 143 Views
The report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021",
E N D
MarketsandMarkets Presents Stem Cell Therapy Market worth $145.8 Million in 2021 http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2021” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW). • Browse 137 market data tables with 17 figures spread through 307 pages and in-depth TOC on Medical Power Supply Market by Technology (AC-DC & DC-DC Power Supply), Type (External, Enclosed, Configurable, Encapsulated) & Application (MRI, X-ray, CT, Ultrasound, EEG, ECG, Blood Pressure Monitor, Ventilator, PAP,VAD- Forecasts to 2017 • http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
This report studies the global stem cell therapy market over the forecast period of 2016 to 2021.The market is poised to grow at a CAGR of 11.0% from 2016 to 2021, to reach $145.8million by 2021. • The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
A number of factors such as the increasing funding from various government and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are stimulating the research activities for stem cell therapies. Developing markets, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies represent high growth opportunities for market players. • In 2015, North America will hold the largest share of the global stem cell therapy market. This large share is primarily attributed to the extensive government funding and increasing fast-track approval for stem cell therapeutics by the FDA. Moreover, development of advanced genomic methods for stem cell analysis and high number of ongoing research activities are further fueling the growth of the stem cell therapy market in North America. However, the Asia-Pacific stem cell therapy market is expected to grow at the highest CAGR in the forecast period, owing to factors such as increasing regulatory support through favorable government policies, strong product pipelines, and increasing licensing activities in this region. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
The stem cell therapy market includes large number of players that are involved in development of stem cell therapies of the treatment of various diseases. Mesoblast Ltd. (Australia), Aastrom Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), and StemCells, Inc. (U.S.) are the key players involved in the development of stem cell therapies across the globe. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
About MarketsandMarkets Markets and Markets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. Markets and Markets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at Markets and Markets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
Contact Us Mr. ShellyMarketsandMarkets™701 Pike Street,Suite 2175, Seattle,WA 98101, United States1-888-600-6441Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html